DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 05 · Volume 58 · September 2025 DOI: 10.1055/s-015-62210

Original Paper

  • 205
    Cendrós, Marc; Catalán, Rosa; Torra, Mercè; Penadés, Rafael; González-Rodríguez, Alexandre; Brunet, Mercè; Perez-Blanco, Josefina; Cullell, Natalia; Serra-Llovich, Alexandre; Hernandez, Marta H.; Arranz, María J.:

    Influence of Glutamate Neurotransmission Genes on the Outcomes of Antipsychotic Treatments

    Open Access
  • 216
    Hsu, Tien-Wei; Tsai, Shih-Jen; Chen, Tzeng-Ji; Chen, Mu-Hong; Liang, Chih-Sung:

    Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study

    Supplementary Material (PDF)
  • 226
    Meshkat, Shakila; Lin, Qiaowei; Tassone, Vanessa K.; Janssen-Aguilar, Reinhard; Lou, Wendy; Bhat, Venkat:

    Association of Physical Activity and Bone Mineral Density in Adults with Depressive Symptoms

    Supplementary Material (PDF)
  • 235
    Chen, Mu-Hong; Su, Tung-Ping; Lin, Wei-Chen; Li, Cheng-Ta; Wu, Hui-Ju; Tsai, Shih-Jen; Bai, Ya-Mei; Mao, Wei-Chung; Tu, Pei-Chi:

    Rapid Antidepressant and Antisuicidal Effects of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression With or Without Low-Grade Inflammation

    • Letter to the Editor

  • 242
    Bonnet, Udo; Scherbaum, Norbert; Juckel, Georg; Bschor, Tom:

    Are Intravenous Subnarcotic Ketamine Infusions as an Adjunct Treatment for Treatment-Resistant Depression Ready to be Recommended in European Guidelines?